The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 0.00 (0.00%)
Spread: 0.50 (0.029%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: Stocks mixed ahead of US Fed, BoE decisions

Wed, 31st Jan 2024 15:49

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

The FTSE 100 closed down 0.47% at 7,630.57 points, while the FTSE 250 managed a modest gain of 0.04%, finishing at 19,357.95 points.

In currency markets, sterling was last 0.23% stronger on the dollar, trading at $1.2729, while it managed a 0.17% uptick against the euro to change hands at €1.1730.

"Today's Fed decision is eagerly awaited by investors who are desperate to see what the Fed will hint at regarding the first rate cut," said IG chief market analyst Chris Beauchamp.

"Much of the ebullient risk appetite we have seen over the past three months has been built on the expectation that the Fed will cut several times this year.

"Given how heavy the selling in Alphabet has been it looks like markets could get quite ugly if the Fed strikes a hawkish tone."

Beauchamp added that it was looking to be a busy 24 hours for currency traders thanks to the proximity of the Fed and BoE meetings.

"Market participants risk being caught between a rock and a hard place; the tight range seen in GBP-USD over the past two weeks screams indecision.

"Hopefully tonight and tomorrow will break the logjam."

House prices top expectations, German inflation moderates

In economic news, house prices in the UK surpassed expectations in January, climbing by 0.7% on the month to rebound from a flat December and defy projections of a 0.1% increase.

The average house price now stood at £257,656.

On an annual basis, January recorded a minor dip of just 0.2%, a stark contrast to the 1.8% decline in the prior month and marking the most robust performance since January last year.

"There have been some encouraging signs for potential buyers recently with mortgage rates continuing to trend down," said Nationwide chief economist Robert Gardner.

"This follows a shift in view amongst investors around the future path of Bank Rate, with investors becoming more optimistic that the Bank of England will lower rates in the years ahead.

"These shifts are important as this led to a decline in the longer-term interest rates - swap rates - that underpin mortgage pricing around the turn of the year."

UK businesses meanwhile started the year on an optimistic note, according to the Lloyds Bank Business Barometer.

Overall confidence soared by nine points in January to reach 44%, representing the largest monthly surge since August and the highest level since February 2022.

Respondents cited factors such as easing inflation and the potential for falling interest rates as driving their optimism.

Broader economic confidence reached 37%, while trading prospects registered at 51%, with hiring intentions also strengthening, as a net balance of 33% expressed plans to increase headcount.

"Businesses are feeling more confident following the cautious end to 2023," said Hann-Ju Ho, senior economist at Lloyds.

"With ongoing political issues and a general election on the horizon, businesses will have factored these into their risk radars and will be working to prepare for any potential impacts on their trading prospects."

In the US, private sector employment figures for January fell short of expectations, with an increase of 107,000, compared to the anticipated 145,000 rise.

Additionally, December's previously reported gain was revised down from 164,000 to 158,000.

The cost of hiring workers in the US meanwhile saw its slowest growth in years during the final quarter of 2023.

According to the Department of Labor, the employment cost index rose by 0.9% on a seasonally adjusted basis for the three months to December, slightly below the consensus estimate of 1.0%.

In Germany, inflation showed signs of moderation in January, with the consumer price index at 2.9%, the lowest since June 2021, in contrast to analysts' expectations of 3.0%.

On a monthly basis, inflation inched up by 0.2%, indicating a decline in energy prices.

"On the face of it, this is a dovish set of numbers, but only marginally and much less dovish than our initial expectations," said Claus Vistesen, chief eurozone economist at Pantheon Macroeconomics.

"Overall, we need to see Thursday's eurozone inflation data before revising or reiterating our call for an European Central Bank rate cut in March.

"For the record, we now think Eurozone inflation stood at 2.7% in January, down 0.1pp from December."

Finally on data, China's factory activity experienced its fourth consecutive month of contraction in January, with the manufacturing purchasing managers' index edging up to 49.2 from December's 49.

The continued struggle in the world's second-largest economy was offset by a strong services sector, leading to a rise in the official non-manufacturing managers' index to 50.7 from 50.4 the previous month, despite weaknesses in the construction industry amid a real estate crisis.

Vodafone falls on end of Iliad deal, Croda jumps almost 5pc

On London's equity markets, Vodafone Group declined 2.08%, taking a hit after French telecoms firm Iliad rejected a revised offer to merge the Italian businesses of both companies.

The revised proposal would have entailed Vodafone receiving €6.6bn in cash and a €2bn shareholder loan, while Iliad would have been granted €400m in cash and a €2bn loan.

On the upside, Croda International added 4.78% after better-than-expected results from US consumer care peer Ashland.

Professional IT services provider FDM Group Holdings managed to recover from earlier losses, closing with a 1.88% gain.

The company earlier indicated that it anticipated flat annual revenues, confirming a previous warning issued in November regarding the impact of geopolitical uncertainties and clients deferring project decisions.

GSK also saw a turnaround in its fortunes, posting a 1.97% increase after it revised its sales outlook for the next seven years.

Chilean copper miner Antofagasta recorded a 1.7% increase after Citi reaffirmed its 'buy' rating on the stock and raised its price target.

Citi emphasised Antofagasta's growth narrative, driven by volume recovery in the next six to 12 months, and the approval of the Centinela expansion, which was expected to contribute 170,000 tonnes of copper production over the medium term at an attractive cost profile.

Reporting by Josh White for Sharecast.com.

Market Movers

FTSE 100 (UKX) 7,630.57 -0.47%

FTSE 250 (MCX) 19,357.95 0.04%

techMARK (TASX) 4,372.25 -0.11%

FTSE 100 - Risers

Croda International (CRDA) 4,805.00p 4.78%

GSK (GSK) 1,568.00p 1.96%

Antofagasta (ANTO) 1,735.00p 1.70%

Severn Trent (SVT) 2,598.00p 1.48%

Flutter Entertainment (DI) (FLTR) 16,285.00p 1.34%

St James's Place (STJ) 654.20p 1.27%

Barratt Developments (BDEV) 540.40p 1.24%

Entain (ENT) 968.20p 1.13%

Smith & Nephew (SN.) 1,110.50p 1.05%

Beazley (BEZ) 544.50p 1.02%

FTSE 100 - Fallers

WPP (WPP) 771.40p -3.04%

Marks & Spencer Group (MKS) 247.30p -2.91%

M&G (MNG) 224.10p -2.44%

B&M European Value Retail S.A. (DI) (BME) 518.60p -2.19%

Vodafone Group (VOD) 67.32p -2.08%

Next (NXT) 8,468.00p -2.04%

Smurfit Kappa Group (CDI) (SKG) 2,948.00p -1.99%

Rolls-Royce Holdings (RR.) 301.20p -1.92%

Tesco (TSCO) 286.60p -1.88%

Airtel Africa (AAF) 112.20p -1.84%

FTSE 250 - Risers

SThree (STEM) 412.00p 3.65%

Lancashire Holdings Limited (LRE) 607.00p 3.41%

Moonpig Group (MOON) 168.00p 2.75%

Ferrexpo (FXPO) 86.80p 2.66%

NCC Group (NCC) 121.20p 2.54%

Hiscox Limited (DI) (HSX) 1,039.00p 2.36%

Telecom Plus (TEP) 1,454.00p 2.25%

Indivior (INDV) 1,387.00p 2.14%

Bakkavor Group (BAKK) 96.00p 2.13%

IG Group Holdings (IGG) 713.50p 1.93%

FTSE 250 - Fallers

Harbour Energy (HBR) 278.80p -5.43%

Wood Group (John) (WG.) 157.50p -5.35%

Tullow Oil (TLW) 31.02p -4.61%

Pets at Home Group (PETS) 280.20p -4.50%

Renishaw (RSW) 3,504.00p -4.31%

Darktrace (DARK) 344.30p -4.23%

Morgan Advanced Materials (MGAM) 271.00p -4.07%

Spirent Communications (SPT) 118.30p -3.43%

Coats Group (COA) 71.60p -3.11%

IP Group (IPO) 52.40p -2.96%

More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.